Request Sample Form


Phone No.*:


Service Intersted In:

Download Complete Report

Your Name*:


Contact Number*:


Service Interested In* (required)

Your Requirment*:

Nubeqa bags FDA green light

The US Food and Drug Administration (FDA) has approved Eli Lilly’s non-steroidal androgen receptor inhibitor (ARi), Nubeqa (darolutamide), for men with non-metastatic castration-resistant prostate cancer.

July 31st, 2019|News|

Neuraxpharm launches first products in UK

Neuraxpharm Group has announced the launch of its first products in the United Kingdom, as well as the appointment of the company’s new general manager Craig Bowen, who will run Neuraxpharm UK, based in Reading.

July 31st, 2019|News|

Role of antimicrobial peptide in infection and cancer treatment

An antimicrobial agent called Defensin kills tumor cells and shrinks tumor size in fruit flies, with help from a pathway that flags the cells for destruction.

July 31st, 2019|News|

WHO: Pretreatment HIV drug resistance exceeds

The drug-resistant form of the virus has been detected at unacceptable levels across Africa, Asia and the Americas.

July 30th, 2019|News|

Researchers build artificial cells that sense and respond to their environment

Scientists have created artificial cells that mimic biological cells by responding to a chemical change in their surroundings.

July 29th, 2019|News|

Search for new semiconductors heats up with gallium oxide

Electrical engineers have cleared another hurdle in high-power semiconductor fabrication by adding the field’s hottest material — beta-gallium oxide — to their arsenal. Beta-gallium oxide is readily available and promises to convert power faster and more efficiently than today’s leading semiconductor materials — gallium nitride and silicon, the researchers […]

July 22nd, 2019|News|

Semi synthetic bacteria: New insights for understanding genetic code

Synthetic biologists seek to create new life with forms and functions not seen in nature. Although scientists are a long way from making a completely artificial life form, they have made semi-synthetic organisms that have an expanded genetic code, allowing them to produce never-before-seen proteins.

July 17th, 2019|News|

Bosch sells packaging machinery division to CVC Capital Partners

Bosch has agreed to sell its packaging machinery division to private equity firm CVC Capital Partners for an undisclosed sum.

July 12th, 2019|News|

Another Alzheimer’s setback as Amgen, Novartis abandon BACE inhibitor trial

After a review of clinical data from the Generation Program studies, Novartis, Amgen and Banner Alzheimer’s Institute have decided to discontinue investigation of the BACE1 inhibitor CNP520 (umibecestat) in two pivotal Phase II/III studies in the Alzheimer’s Prevention Initiative Generation Program.

July 12th, 2019|News|

Orphan Drug Designation granted for AZ’ Imfinzi

AstraZeneca has announced that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to Imfinzi (durvalumab) for the treatment of small cell lung cancer (SCLC).

July 12th, 2019|News|